These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1222 related articles for article (PubMed ID: 18500230)

  • 21. rs224136 on chromosome 10q21.1 and variants in PHOX2B, NCF4, and FAM92B are not major genetic risk factors for susceptibility to Crohn's disease in the German population.
    Glas J; Seiderer J; Pasciuto G; Tillack C; Diegelmann J; Pfennig S; Konrad A; Schmechel S; Wetzke M; Török HP; Stallhofer J; Jürgens M; Griga T; Klein W; Epplen JT; Schiemann U; Mussack T; Lohse P; Göke B; Ochsenkühn T; Folwaczny M; Müller-Myhsok B; Brand S
    Am J Gastroenterol; 2009 Mar; 104(3):665-72. PubMed ID: 19262523
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The genetic basis of inflammatory bowel disease.
    Cooney R; Jewell D
    Dig Dis; 2009; 27(4):428-42. PubMed ID: 19897957
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The genetics universe of Crohn's disease and ulcerative colitis.
    Parkes M
    Dig Dis; 2012; 30 Suppl 1():78-81. PubMed ID: 23075873
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Susceptibility genes and overall pathogenesis of inflammatory bowel disease: where do we stand?
    Fiocchi C
    Dig Dis; 2009; 27(3):226-35. PubMed ID: 19786745
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanisms and efficacy of immunobiologic therapies for inflammatory bowel diseases.
    Ghosh N; Chaki R; Mandal V; Lin GD; Mandal SC
    Int Rev Immunol; 2010; 29(1):4-37. PubMed ID: 20100080
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Towards a molecular risk map--recent advances on the etiology of inflammatory bowel disease.
    Rosenstiel P; Sina C; Franke A; Schreiber S
    Semin Immunol; 2009 Dec; 21(6):334-45. PubMed ID: 19926490
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Etiology and pathogenesis of inflammatory bowel disease.
    Schmidt C; Stallmach A
    Minerva Gastroenterol Dietol; 2005 Jun; 51(2):127-45. PubMed ID: 15990703
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Review article: genetic susceptibility and application of genetic testing in clinical management of inflammatory bowel disease.
    Vermeire S
    Aliment Pharmacol Ther; 2006 Oct; 24 Suppl 3():2-10. PubMed ID: 16961737
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A primary dysregulation in the immunoregulatory role of the intestinal mucosal epithelial cell in inflammatory bowel disease pathogenesis? Biology of inflammatory response as tissue pattern entities in Crohn's versus ulcerative colitis.
    Agius LM
    J Theor Biol; 2004 Mar; 227(2):219-28. PubMed ID: 14990386
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inflammatory bowel disease and innate immune response genes: the challenge of complex polygenic disorders for the clinical geneticist.
    Haigh B
    Clin Genet; 2006 Apr; 69(4):315-8. PubMed ID: 16630164
    [No Abstract]   [Full Text] [Related]  

  • 31. IL-10 and IL-10 receptor defects in humans.
    Glocker EO; Kotlarz D; Klein C; Shah N; Grimbacher B
    Ann N Y Acad Sci; 2011 Dec; 1246():102-7. PubMed ID: 22236434
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gene-gene interactions in inflammatory bowel disease: biological and clinical implications.
    Achkar JP; Fiocchi C
    Am J Gastroenterol; 2009 Jul; 104(7):1734-6. PubMed ID: 19436278
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The immunological and genetic basis of inflammatory bowel disease.
    Bouma G; Strober W
    Nat Rev Immunol; 2003 Jul; 3(7):521-33. PubMed ID: 12876555
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Advances in the molecular dissection of inflammatory bowel disease.
    Siminovitch KA
    Semin Immunol; 2006 Aug; 18(4):244-53. PubMed ID: 16679026
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Attitudes toward genetic testing in patients with inflammatory bowel disease.
    Lal S; Appelton J; Mascarenhas J; Stempak JM; Esplen MJ; Silverberg MS
    Eur J Gastroenterol Hepatol; 2007 Apr; 19(4):321-7. PubMed ID: 17353697
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Abnormal mucosal immune response to altered bacterial flora following restorative proctocolectomy in patients with ulcerative colitis: serologic measures, immunogenetics, and clinical correlations.
    Sheikh S; Uno J; Matsuoka K; Plevy S
    Clin Immunol; 2008 Jun; 127(3):270-9. PubMed ID: 18499066
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of Australian Crohn's disease pedigrees refines the localization for susceptibility to inflammatory bowel disease on chromosome 16.
    Cavanaugh JA; Callen DF; Wilson SR; Stanford PM; Sraml ME; Gorska M; Crawford J; Whitmore SA; Shlegel C; Foote S; Kohonen-Corish M; Pavli P
    Ann Hum Genet; 1998 Jul; 62(Pt 4):291-8. PubMed ID: 9924607
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Pathogenetic models ulcerative colitis and Crohn disease].
    Feller AC; Löhler J; Reimann J; Merz H
    Verh Dtsch Ges Pathol; 1996; 80():104-8. PubMed ID: 9064992
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of a CXCL9 polymorphism with pediatric Crohn's disease.
    Lacher M; Kappler R; Berkholz S; Baurecht H; von Schweinitz D; Koletzko S
    Biochem Biophys Res Commun; 2007 Nov; 363(3):701-7. PubMed ID: 17892861
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The incidence of inflammatory bowel disease in a rural region of Southern Germany: a prospective population-based study.
    Ott C; Obermeier F; Thieler S; Kemptner D; Bauer A; Schölmerich J; Rogler G; Timmer A
    Eur J Gastroenterol Hepatol; 2008 Sep; 20(9):917-23. PubMed ID: 18794607
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 62.